Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Citrulline in MELAS Syndrome
NCT03952234Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Apr 2021
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of citrulline in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), sponsored by Baylor College of Medicine. Started Apr 2021; status: completed.
02
Drugs
citrulline
03
Conditions
mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)
Beyond the preview
Go deeper on NCT03952234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03952234.